Omics techniques and biobanks to find new biomarkers for the early detection of acute lymphoblastic leukemia in middle-income countries: a perspective from Mexico


Por: Alejandro Aguirre-Guillen, William, Angeles-Floriano, Tania, Lopez-Martinez, Briceida, Reyes-Morales, Hortensia, Zlotnik, Albert, Valle-Rios, Ricardo

Publicada: 1 may 2017
Categoría: Pediatrics, perinatology and child health

Resumen:
Acute lymphoblastic leukemia (ALL) affects the quality of life of many children in the world and particularly in Mexico, where a high incidence has been reported. With a proper financial investment and with well-organized institutions caring for those patients, together with solid platforms to perform high-throughput analyses, we propose the creation of a Mexican repository system of serum and cells from bone marrow and blood samples derived from tissues of pediatric patients with ALL diagnosis. This resource, in combination with omics technologies, particularly proteomics and metabolomics, would allow longitudinal studies, offering an opportunity to design and apply personalized ALL treatments. Importantly, it would accelerate the development of translational science and will lead us to further discoveries, including the identification of new biomarkers for the early detection of leukemia. (C) 2017 Hospital Infantil de Mexico Federico Gomez. Published by Masson Doyma Mexico S. A. This is an open access article under the CC BY-NC-ND license.

Filiaciones:
Alejandro Aguirre-Guillen, William:
 Hosp Infantil Mexico Dr Federico Gomez, Lab Invest Inmunol & Prote, Mexico City, DF, Mexico

 Univ Autonoma Metropolitana, Unidad Biol & Ciencias Salud, Mexico City, DF, Mexico

Angeles-Floriano, Tania:
 Hosp Infantil Mexico Dr Federico Gomez, Lab Invest Inmunol & Prote, Mexico City, DF, Mexico

 Hosp Infantil Mexico Dr Federico Gomez, Dept Lab Clin, Mexico City, DF, Mexico

Lopez-Martinez, Briceida:
 Hosp Infantil Mexico Dr Federico Gomez, Subdirecc Diagnost Clin, Mexico City, DF, Mexico

Reyes-Morales, Hortensia:
 Hosp Infantil Mexico Dr Federico Gomez, Dept Invest, Mexico City, DF, Mexico

Zlotnik, Albert:
 Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92717 USA

 Univ Calif Irvine, Inst Immunol, Irvine, CA USA

Valle-Rios, Ricardo:
 Hosp Infantil Mexico Dr Federico Gomez, Lab Invest Inmunol & Prote, Mexico City, DF, Mexico

 Univ Nacl Autonoma Mexico, Unidad Invest, Escuela Med, Mexico City, DF, Mexico
ISSN: 05396115
Editorial
HOSPITAL INFANTIL MEXICO, FEDERICO GOMEZ, DEPT EDICIONES MEDICAS, CALLE DR MARQUEZ 162 COL DOCTORES, DELEG CUAUHTEMOC, MEXICO CITY 06720, MEXICO, México
Tipo de documento: Review
Volumen: 74 Número: 3
Páginas: 227-232
WOS Id: 000414325100009
ID de PubMed: 29382491